Newstin ORGANIZING THE NEWS

THIS WEEK'S PICKS

in all

New to Newstin? Take a look at what we are doing...

* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Full Coverage

Boston Scientific Announces Results for Second Quarter Ended June 30, 2008

prnewswire.com

Jul 21, 2008

Story Timeline: 78 days

Boston Scientific Announces Results for Second Quarter Ended June 30, 2008 NATICK, Mass., July 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2008, as well as guidance for net sales and earnings per share (EPS) for the third quarter of 2008. Second quarter highlights: -- Achieved net sales of $2.024 billion -- Reported adjusted EPS of $0.20, an increase of 25 percent over prior year -- Increased Cardiac Rhythm Management (CRM) sales 10 percent -- Endosurgery sales growth of 12 percent -- Received FDA approval for COGNIS(TM) CRT-D and TELIGEN(TM) ICD -- Obtained US and European approval for ALTRUA(TM) family of pacemakers -- Paid down $300 million of debt -- Reduced SG&A and R&D expenses by $119 million below prior year "We were... [read full story]

Add Comment